Prognostic markers in stage I oral cavity squamous cell carcinoma
- 5 August 2013
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 123 (10) , 2435-2441
Abstract
Objectives/Hypothesis: Early‐stage oral squamous cell carcinoma (OSCC) treatment is based on anatomic location, clinical TNM staging, and histological grade. It is a heterogeneous disease group. Classification of patients with OSCC by immunohistochemical analysis of established oncoproteins and evaluate disease course was our primary objective. Characterization of stage I OSCC patients in Southwest Finland was our secondary objective.Study Design: Immunohistochemical analysis of tumor specimens and retrospective analysis of patient data of the patient treated in Turku University Hospital for T1N0M0 OSCC during the years 2000‐2004.Methods: Paraffin‐embedded tumor specimens from 35 OSCC patients were collected and analyzed for HIF‐1α, CD44, p16, Ki67, and podoplanin by immunohistochemistry and correlated with clinical findings.Results: Tumoral CD44 and HIF1‐α expression levels, in combination, predicted 5‐year disease‐free survival. Reduced expression of CD44 and elevated expression of HIF1‐α is associated with the lowest probability of disease‐free survival compared to the population as a whole (P < .001 in Kaplan‐Meier analysis). Patients with grade I tumors demonstrated improved disease‐specific survival compared to those with grade II tumors (P = .027). No association was seen between p16 expression, Ki67 labeling index, or podoplanin expression and prognosis in our 35 specimens.Conclusions: HIF‐1α and CD44 immunohistochemical detection could potentially serve as a prognostic tool in therapy selection for early‐stage OSCC. Laryngoscope, 123:2435–2441, 2013Keywords
This publication has 29 references indexed in Scilit:
- Role of Hyaluronan-Mediated CD44 Signaling in Head and Neck Squamous Cell Carcinoma Progression and ChemoresistanceThe American Journal of Pathology, 2011
- Current and emerging biomarkers in breast cancer: prognosis and predictionEndocrine-Related Cancer, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Global epidemiology of oral and oropharyngeal cancerOral Oncology, 2009
- Tumor microenvironment in head and neck squamous cell carcinomas: Predictive value and clinical relevance of hypoxic markers. A reviewHead & Neck, 2007
- Overexpression of podoplanin in oral cancer and its association with poor clinical outcomeCancer, 2006
- Prognostic relevance of molecular markers of oral cancer—A reviewInternational Journal of Oral and Maxillofacial Surgery, 2003
- Angiosarcomas Express Mixed Endothelial Phenotypes of Blood and Lymphatic CapillariesThe American Journal of Pathology, 1999
- Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformationBritish Journal of Cancer, 1997
- Prognostic factors in head and neck cancer: Histologic grading, dna ploidy, and nodal statusHead & Neck, 1991